in this issue
Regions :: Western Europe :: Belgium
Solvay Reports a Fall in Profits and Sales
1:12 AM MDT | July 30, 2009 | Deepti Ramesh
Solvay reported a 36% decrease in second-quarter 2009 net profits, to €83 million, compared with the corresponding period of 2008, on sales down 12%, to €2.06 billion. The Pharmaceuticals segment of Solvay recorded a 11% increase in sales for the second quarter, to €661 million, compared with the year-ago period. The recurring Ebit for the segment increased by 4%, to €115 million. The segment benefited from the sustained growth of certain drugs, the overall positive exchange rate effects and the continued improvement of sales from emerging...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee